Pulse Biosciences (PLSE:NASDAQ) Investor Relations Material

Overview

Hayward-based Pulse Biosciences, Inc. is an innovative bioelectric medicine company that specializes in providing non-thermal treatments for a range of medical conditions. Through its groundbreaking Nano-Pulse Stimulation technology, the company offers its CellFX System, which is a platform that provides nano second duration pulses of electrical energy to targeted cells while leaving adjacent non-cellular tissue unharmed. The device is tunable, software-enabled, and console-based, offering a highly effective treatment option. With its origins as Electroblate, Inc., Pulse Biosciences, Inc. was incorporated in 2014 and rebranded with its current name in December 2015.

Frequently Asked Questions

What is Pulse Biosciences's ticker?

Pulse Biosciences's ticker is PLSE

What exchange is Pulse Biosciences traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Pulse Biosciences's headquarters?

They are based in Hayward, California

How many employees does Pulse Biosciences have?

There are 51-200 employees working at Pulse Biosciences

What is Pulse Biosciences's website?

It is pulsebiosciences.com

What type of sector is Pulse Biosciences?

Pulse Biosciences is in the Healthcare sector

What type of industry is Pulse Biosciences?

Pulse Biosciences is in the Medical Instruments & Supplies industry

Who are Pulse Biosciences's peers and competitors?

The following five companies are Pulse Biosciences's industry peers:

- Alphatec

- BioLife Solutions

- Insulet

- Nephros

- Senseonics